05 June 2024
05 June 2024
At the ASCO conference, investigators highlighted the potential of Moderna’s cancer vaccine combination based on Phase II data.
Keeping high-qualified, experienced clinical trial staff on board plays a crucial role in bringing new drugs to market.
Sarclisa is looking to make a dent in the anti-CD38 multiple myeloma treatment market dominated by J&J’s Darzalex.
While noting improvement in patient symptoms, an FDA advisory committee was not convinced by Lykos’ trial design.
RINVOQ LQ oral solution is also available for paediatric polyarticular juvenile idiopathic arthritis and psoriatic arthritis patients.
More than two-thirds of drugs that could be at stake due to the BIOSECURE Act were developed by US-based public companies.
Alligator Bioscience’s CEO says that its pancreatic cancer drug may mark a meaningful improvement on current treatment standards.
Approvals are being sought for PREZCOBIX/REZOLSTA use in paediatric patients weighing at least 25kg.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
